Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention (Q34615197)

3 August 2017

title

Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention (English)

1 reference

3 August 2017

main subject

phase II clinical trial

0 references

1 reference

1 reference

Christopher J Gostout

16

object named as

Christopher Gostout

1 reference

3 August 2017

18

Thomas C Smyrk

1 reference

3 August 2017

2

Michelle R Mahoney

1 reference

3 August 2017

1

Paul J Limburg

1 reference

3 August 2017

Katie L Allen Ziegler

3

object named as

Katie L Allen Ziegler

1 reference

3 August 2017

13

Gary Della'Zanna

1 reference

3 August 2017

15

Ellen Richmond

1 reference

Cancer Prevention Network

3 August 2017

19

object named as

Cancer Prevention Network

1 reference

3 August 2017

Stephen J Sontag

4

1 reference

3 August 2017

Robert E Schoen

5

1 reference

3 August 2017

Richard Benya

6

1 reference

3 August 2017

Michael J Lawson

7

1 reference

3 August 2017

David S Weinberg

8

1 reference

3 August 2017

Elena Stoffel

9

1 reference

3 August 2017

Michael Chiorean

10

1 reference

3 August 2017

Russell Heigh

11

1 reference

3 August 2017

Joel Levine

12

1 reference

3 August 2017

Luz Rodriguez

14

1 reference

3 August 2017

Sumithra J Mandrekar

17

1 reference

3 August 2017

language of work or name

1 reference

5 January 2011

1 reference

Cancer Prevention Research

3 August 2017

published in

1 reference

3 August 2017

volume

4

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

259-269

1 reference

One year recurrence of aberrant crypt foci

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

7 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Chemoprevention of colorectal cancer: feasibility in everyday practice?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Chronic statin therapy and the risk of colorectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Statins in tumor suppression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Chemoprevention of colorectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Aberrant crypt foci: what we know and what we need to know

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Colorectal cancer chemoprevention--an overview of the science

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Aberrant crypt foci of the colon as precursors of adenoma and cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Effects of sulindac on sporadic colorectal adenomatous polyps

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Effect of sulindac on sporadic colonic polyps.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

A multicenter study of prevalence and risk factors for aberrant crypt foci

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Aberrant crypt foci in the adenoma prevention with celecoxib trial

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

The natural history of aberrant crypt foci.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

NSAID effect on sporadic colon polyps.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3046804

Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention

26 October 2018

1 reference

12 December 2020

Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia

1 reference

12 December 2020

Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort

1 reference

12 December 2020

Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients

1 reference

12 December 2020

Long-Term Use of Statins and Risk of Colorectal Cancer: A Population-Based Study

1 reference

12 December 2020

10.1158/1940-6207.CAPR-10-0215

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference